BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 24002538)

  • 1. Borderline resectable/locally advanced pancreatic adenocarcinoma: improvements needed in population-based registries.
    Miura JT; Evans DB; Pappas SG; Gamblin TC; Turaga KK
    Ann Surg Oncol; 2013 Dec; 20(13):4338-47. PubMed ID: 24002538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. En bloc vascular resection for locally advanced pancreatic malignancies infiltrating major blood vessels: perioperative outcome and long-term survival in 136 patients.
    Yekebas EF; Bogoevski D; Cataldegirmen G; Kunze C; Marx A; Vashist YK; Schurr PG; Liebl L; Thieltges S; Gawad KA; Schneider C; Izbicki JR
    Ann Surg; 2008 Feb; 247(2):300-9. PubMed ID: 18216537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of total lymph node count and lymph node ratio on staging and survival after pancreatectomy for pancreatic adenocarcinoma: a large, population-based analysis.
    Slidell MB; Chang DC; Cameron JL; Wolfgang C; Herman JM; Schulick RD; Choti MA; Pawlik TM
    Ann Surg Oncol; 2008 Jan; 15(1):165-74. PubMed ID: 17896141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reassessment of the clinical significance of portal-superior mesenteric vein invasion in borderline resectable pancreatic cancer.
    Hoshimoto S; Hishinuma S; Shirakawa H; Tomikawa M; Ozawa I; Wakamatsu S; Hoshi S; Hoshi N; Hirabayashi K; Ogata Y
    Eur J Surg Oncol; 2017 Jun; 43(6):1068-1075. PubMed ID: 28427822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arterial and venous resection for pancreatic adenocarcinoma: operative and long-term outcomes.
    Martin RC; Scoggins CR; Egnatashvili V; Staley CA; McMasters KM; Kooby DA
    Arch Surg; 2009 Feb; 144(2):154-9. PubMed ID: 19221327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Locally advanced pancreatic cancer: association between prolonged preoperative treatment and lymph-node negativity and overall survival.
    Kadera BE; Sunjaya DB; Isacoff WH; Li L; Hines OJ; Tomlinson JS; Dawson DW; Rochefort MM; Donald GW; Clerkin BM; Reber HA; Donahue TR
    JAMA Surg; 2014 Feb; 149(2):145-53. PubMed ID: 24306217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 672 patients with acinar cell carcinoma of the pancreas: a population-based comparison to pancreatic adenocarcinoma.
    Wisnoski NC; Townsend CM; Nealon WH; Freeman JL; Riall TS
    Surgery; 2008 Aug; 144(2):141-8. PubMed ID: 18656619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. En bloc resection for locally advanced cancer of the pancreas: is it worthwhile?
    Sasson AR; Hoffman JP; Ross EA; Kagan SA; Pingpank JF; Eisenberg BL
    J Gastrointest Surg; 2002; 6(2):147-57; discussion 157-8. PubMed ID: 11992799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival after resection of pancreatic adenocarcinoma: results from a single institution over three decades.
    Winter JM; Brennan MF; Tang LH; D'Angelica MI; Dematteo RP; Fong Y; Klimstra DS; Jarnagin WR; Allen PJ
    Ann Surg Oncol; 2012 Jan; 19(1):169-75. PubMed ID: 21761104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Locally advanced pancreatic duct adenocarcinoma: pancreatectomy with planned arterial resection based on axial arterial encasement.
    Perinel J; Nappo G; El Bechwaty M; Walter T; Hervieu V; Valette PJ; Feugier P; Adham M
    Langenbecks Arch Surg; 2016 Dec; 401(8):1131-1142. PubMed ID: 27476146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative analysis of survival outcomes between pancreatectomy and chemotherapy for elderly patients with adenocarcinoma of the pancreas.
    Marmor S; Burke EE; Virnig BA; Jensen EH; Tuttle TM
    Cancer; 2016 Nov; 122(21):3378-3385. PubMed ID: 27419382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is the need for an arterial resection a contraindication to pancreatic resection for locally advanced pancreatic adenocarcinoma? A case-matched controlled study.
    Bachellier P; Rosso E; Lucescu I; Oussoultzoglou E; Tracey J; Pessaux P; Ferreira N; Jaeck D
    J Surg Oncol; 2011 Jan; 103(1):75-84. PubMed ID: 21105000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of lymph node number on survival in patients with lymph node-negative pancreatic cancer.
    Hellan M; Sun CL; Artinyan A; Mojica-Manosa P; Bhatia S; Ellenhorn JD; Kim J
    Pancreas; 2008 Jul; 37(1):19-24. PubMed ID: 18580439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic factors in resected pancreatic adenocarcinoma: analysis of actual 5-year survivors.
    Cleary SP; Gryfe R; Guindi M; Greig P; Smith L; Mackenzie R; Strasberg S; Hanna S; Taylor B; Langer B; Gallinger S
    J Am Coll Surg; 2004 May; 198(5):722-31. PubMed ID: 15110805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new preoperative prognostic scoring system to predict prognosis in patients with locally advanced pancreatic body cancer who undergo distal pancreatectomy with en bloc celiac axis resection: a retrospective cohort study.
    Miura T; Hirano S; Nakamura T; Tanaka E; Shichinohe T; Tsuchikawa T; Kato K; Matsumoto J; Kondo S
    Surgery; 2014 Mar; 155(3):457-67. PubMed ID: 24462074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of S100A2 calcium-binding protein predicts response to pancreatectomy for pancreatic cancer.
    Biankin AV; Kench JG; Colvin EK; Segara D; Scarlett CJ; Nguyen NQ; Chang DK; Morey AL; Lee CS; Pinese M; Kuo SC; Susanto JM; Cosman PH; Lindeman GJ; Visvader JE; Nguyen TV; Merrett ND; Warusavitarne J; Musgrove EA; Henshall SM; Sutherland RL;
    Gastroenterology; 2009 Aug; 137(2):558-68, 568.e1-11. PubMed ID: 19376121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tips and tricks of the surgical technique for borderline resectable pancreatic cancer: mesenteric approach and modified distal pancreatectomy with en-bloc celiac axis resection.
    Hirono S; Yamaue H
    J Hepatobiliary Pancreat Sci; 2015 Feb; 22(2):E4-7. PubMed ID: 25366360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical resection after radiochemotherapy in patients with unresectable adenocarcinoma of the pancreas.
    Sa Cunha A; Rault A; Laurent C; Adhoute X; Vendrely V; Béllannée G; Brunet R; Collet D; Masson B
    J Am Coll Surg; 2005 Sep; 201(3):359-65. PubMed ID: 16125068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Indication and results of pancreatectomy with combined resection of vessels for adenocarcinoma of the pancreas].
    Ogata Y; Hishinuma S; Takahashi S; Matsui J; Ozawa I
    Nihon Geka Gakkai Zasshi; 1997 Jul; 98(7):615-21. PubMed ID: 9276868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The incidence and outcomes of pancreatectomy in patients with metastatic pancreatic adenocarcinoma.
    McKenzie S; Mailey B; Artinyan A; Kim J; Ellenhorn JD
    JOP; 2010 Jul; 11(4):341-7. PubMed ID: 20601808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.